Global 3D Cell Culture Market, By Product (Scaffold-Based, Scaffold-Free, Microfluidics-Based, Magnetic Levitation and 3D Bio-printing), Type (Hydrogel, Hanging Drop, Bioreactor, Microfluidics, Magnetic Levitation), Application (Cancer and Stem Cell Research, Drug Discovery and Toxicology Testing, Tissue Engineering and Regenerative Medicine), End User (Pharmaceutical and Biotechnology Companies, Academic, Institutes, Research Laboratories) – Industry Trends and Forecast to 2030.
3D Cell Culture Market Analysis and Size
The increasing demand and the introduction of 3D cell culture based on microfluidics is driving market growth. The industry is expected to be transformed by the shift from traditional cell culture techniques to 3D techniques. Furthermore, research project funding for doctorate academic ventures utilizing this technology is expected to augment demand for three-dimensional culture systems, resulting in industry growth. However, high costs of cell biology research and a lack of 3D cell-based testing facilities are expected to obstruct market development during the forecast period.
Data Bridge Market Research analyses that the 3D cell culture market which was USD 2028.85 million in 2022, is expected to reach USD 6743.71 million by 2030, at a CAGR of 16.2% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
3D Cell Culture Market Scope and Segmentation
2023 to 2030
2021 (Customizable to 2015 - 2020)
Revenue in USD Million, Volumes in Units, Pricing in USD
Product (Scaffold-Based, Scaffold-Free, Microfluidics-Based, Magnetic Levitation and 3D Bio-printing), Type (Hydrogel, Hanging Drop, Bioreactor, Microfluidics, Magnetic Levitation), Application (Cancer and Stem Cell Research, Drug Discovery and Toxicology Testing, Tissue Engineering and Regenerative Medicine), End User (Pharmaceutical and Biotechnology Companies, Academic, Institutes, Research Laboratories)
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
Market Players Covered
REPROCELL Inc. (Japan), Nanofiber Solutions (U.S.), SYNTHECON, INCORPORATED (U.S.), InSphero (Switzerland), Merck KGaA (Germany), VWR International, LLC. (U.S.), Lonza (Switzerland), Agilent Technologies (U.S.), Corning Incorporated (U.S.), Cell Culture Company, LLC (U.S.), Advanced Instruments (U.S.), SHIBUYA CORPORATION (Japan), NanoEntek (U.S.), FUJIFILM Holdings America Corporation (U.S.), Hitachi, Ltd. (Japan), Thermo Fisher Scientific Holdings, Inc. (U.S.), BD (U.S.)
3D cell culture is an in-vitro technique that involves creating an artificial environment and then allowing biological cells to formulate, grow, or interact with their surroundings in all three dimensions. 3D cell culture differentiates and migrates from normal cells by reacting to their three-dimensional surroundings. The increased utility of the cell aids in tissue maturation and organization. This technique is widely used in pharmaceutical and biotechnology companies, as well as academic institutions and research labs.
3D Cell Culture Market Dynamics
- Development of 3d cell culture based on microfluidics
Recent advances in 3D cell culture microfluidics have enabled the creation of microenvironments that promote tissue differentiation and mimic the tissue-tissue interface, chemical gradients, and spatiotemporal as well as mechanical microenvironments found in real organs. This 3D cell culture model allows for studying human physiology in an accordion setting, developing in vitro disease models, and eventually replacing animal models in drug development and toxicity assessment. These are the advancements which propel the market.
- The emergence of 3D cell culture using microfluidics
Key players in the 3D cell culture market are forming partnerships and collaborations with pharmaceutical companies to strengthen their market position. This strategy enables market participants to evaluate the performance of different organs-on-chips. For instance, opportunities for drug development and other pharmaceutical research CN Bio, announced a research collaboration in November 2021 aimed at validating novel organ-on-a-chip infection models. In July 2021, MIMETAS and Roche announced a collaboration to develop human disease models to characterise novel compounds in inflammatory bowel disease (BD) and B virus infections. These are the certain factors which propel the market growth.
- Introduction of new products
Several other major factors driving market growth include the introduction of new products and the widespread use of 3D protocols in biological research. For instance, eNUVIO Inc., a biotechnology company based in Canada, will launch EB-Plate, a completely reusable microplate for 3D cell culture, in December 2020. This is expected to reduce single-use plastic waste, increase the utility of 3-dimensional microplates, and accelerate the zero-waste.
- Dearth of consistency in products being developed through 3d cell culture
The use of scaffolds to support three-dimensional cell cultures has expanded the scope of research opportunities. However, the presence of different growth factors in scaffolds causes variation from batch to batch. This makes biological research on signalling pathways and pharmacological studies difficult. Although cells grown on scaffolds with low growth factors had phenotypes comparable to those grown on scaffolds with high growth factors, the proliferation rate remained extremely high.
This 3D cell culture market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the 3D cell culture market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
- In 2022, Avantor collaborated with GeminiBio, a supplier of biological products and chemical reagents. The companies hoped to meet the biotechnology industry's demand for collaboration on bioproduction workflow solutions through this collaboration.
- InMay 2022, Lonza signed an agreement with Israel Biotech Fund, a venture capital firm. The companies signed this agreement to speed up the production and development of Israeli small molecules and biologics. Furthermore, IBF would provide Lonza with access to its portfolio companies as well as its extensive network in the Israeli biotech industry.
Global 3D Cell Culture Market Scope
The 3D cell culture market is segmented on the basis of product, type, application and end use. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
- Hydrogels/ECM analogs
- Solid scaffolds
- Micropatterned surfaces
- Low-adhesion microplates
- Hanging drop plates
- 3d bioreactors
- 3d petri dishes
- Magnetic Levitation and 3D Bio-printing
- Hanging Drop
- Magnetic Levitation
- Cancer and Stem Cell Research
- Drug Discovery and Toxicology Testing
- Tissue Engineering and Regenerative Medicine
- Pharmaceutical and Biotechnology Companies
- Research Laboratories
3D Cell Culture Market Regional Analysis/Insights
The 3D cell culture market is analysed and market size insights and trends are provided by country, product, type, application and end use as referenced above.
The countries covered in the 3D cell culture market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the 3D cell culture market due to the availability of new and improved technology to cure cancer and the establishment of pharmaceutical and biotechnology industries.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 due to the growing focus of the drug delivery and increase in the pharmaceutical and biotechnology industries.
The country section of the report also provides individual market impacting factors and domestic regulation changes that impact the market's current and future trends. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The 3D cell culture market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for 3D cell culture market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the 3D cell culture market. The data is available for historic period 2011-2021.
Competitive Landscape and 3D Cell Culture Market Share Analysis
The 3D cell culture market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to 3D cell culture market.
Some of the major players operating in the 3D cell culture market are:
- REPROCELL Inc. (Japan)
- Nanofiber Solutions (U.S.)
- SYNTHECON, INCORPORATED (U.S.)
- InSphero (Switzerland)
- Merck KGaA (Germany)
- VWR International, LLC. (U.S.)
- Lonza (Switzerland)
- Agilent Technologies (U.S.)
- Corning Incorporated (U.S.)
- Cell Culture Company, LLC (U.S.)
- Advanced Instruments (U.S.)
- SHIBUYA CORPORATION (Japan)
- NanoEntek (U.S.)
- FUJIFILM Holdings America Corporation (U.S.)
- Hitachi, Ltd. (Japan)
- Thermo Fisher Scientific Holdings, Inc. (U.S.)
- BD (U.S.)